YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) Sees Large Growth in Short Interest

YieldMax MRNA Option Income Strategy ETF (NYSEARCA:MRNY) saw a large increase in short interest in the month of September. As of September 15th, there was short interest totaling 80,671 shares, an increase of 57.3% from the August 31st total of 51,284 shares. Approximately 1.5% of the shares of the company are sold short. Based on an average trading volume of 218,763 shares, the days-to-cover ratio is currently 0.4 days.

YieldMax MRNA Option Income Strategy ETF Trading Down 3.8%

YieldMax MRNA Option Income Strategy ETF stock traded down $1.60 during midday trading on Wednesday, hitting $40.21. The stock had a trading volume of 512,731 shares, compared to its average volume of 243,641. The firm’s fifty day moving average is $27.20 and its two-hundred day moving average is $20.93. YieldMax MRNA Option Income Strategy ETF has a 52-week low of $13.60 and a 52-week high of $42.63.

YieldMax MRNA Option Income Strategy ETF Company Profile

The YieldMax MRNA Option Income Strategy ETF (MRNY) is an exchange-traded fund that mostly invests in health care equity. The fund seeks to provide current income and capped gains on the Moderna stock (MRNA) through a synthetic covered call strategy, collateralized by cash and US Treasurys. The actively managed fund uses both standardized exchange-traded and FLEX options. MRNY was launched on Oct 23, 2023 and is issued by YieldMax.